Literature DB >> 27163456

Negative control of CSL gene transcription by stress/DNA damage response and p53.

Elena Menietti1, Xiaoying Xu1, Paola Ostano2, Jean-Marc Joseph3, Karine Lefort1,4, G Paolo Dotto1,5.   

Abstract

CSL is a key transcriptional repressor and mediator of Notch signaling. Despite wide interest in CSL, mechanisms responsible for its own regulation are little studied. CSL down-modulation in human dermal fibroblasts (HDFs) leads to conversion into cancer associated fibroblasts (CAF), promoting keratinocyte tumors. We show here that CSL transcript levels differ among HDF strains from different individuals, with negative correlation with genes involved in DNA damage/repair. CSL expression is negatively regulated by stress/DNA damage caused by UVA, Reactive Oxygen Species (ROS), smoke extract, and doxorubicin treatment. P53, a key effector of the DNA damage response, negatively controls CSL gene transcription, through suppression of CSL promoter activity and, indirectly, by increased p21 expression. CSL was previously shown to bind p53 suppressing its activity. The present findings indicate that p53, in turn, decreases CSL expression, which can serve to enhance p53 activity in acute DNA damage response of cells.

Entities:  

Keywords:  CSL/RBPJκ; UVA/DNA damage response; dermal fibroblasts; individual variations in gene transcription; p53

Mesh:

Substances:

Year:  2016        PMID: 27163456      PMCID: PMC4957600          DOI: 10.1080/15384101.2016.1186317

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  55 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

2.  Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling.

Authors:  Bing Hu; Einar Castillo; Louise Harewood; Paola Ostano; Alexandre Reymond; Reinhard Dummer; Wassim Raffoul; Wolfram Hoetzenecker; Günther F L Hofbauer; G Paolo Dotto
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

3.  Control of hair follicle cell fate by underlying mesenchyme through a CSL-Wnt5a-FoxN1 regulatory axis.

Authors:  Bing Hu; Karine Lefort; Wenying Qiu; Bach-Cuc Nguyen; Renuga Devi Rajaram; Einar Castillo; Fenglei He; Yiping Chen; Peter Angel; Cathrin Brisken; G Paolo Dotto
Journal:  Genes Dev       Date:  2010-07-15       Impact factor: 11.361

4.  p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype.

Authors:  Adam Freund; Christopher K Patil; Judith Campisi
Journal:  EMBO J       Date:  2011-03-11       Impact factor: 11.598

Review 5.  Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging.

Authors:  S Kawanishi; Y Hiraku; S Oikawa
Journal:  Mutat Res       Date:  2001-03       Impact factor: 2.433

6.  The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.

Authors:  Kristen L Meerbrey; Guang Hu; Jessica D Kessler; Kevin Roarty; Mamie Z Li; Justin E Fang; Jason I Herschkowitz; Anna E Burrows; Alberto Ciccia; Tingting Sun; Earlene M Schmitt; Ronald J Bernardi; Xiaoyong Fu; Christopher S Bland; Thomas A Cooper; Rachel Schiff; Jeffrey M Rosen; Thomas F Westbrook; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-09       Impact factor: 11.205

Review 7.  Crosstalk of Notch with p53 and p63 in cancer growth control.

Authors:  G Paolo Dotto
Journal:  Nat Rev Cancer       Date:  2009-07-16       Impact factor: 60.716

8.  Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.

Authors:  Patsy S H Soon; Edward Kim; Cindy K Pon; Anthony J Gill; Katrina Moore; Andrew J Spillane; Diana E Benn; Robert C Baxter
Journal:  Endocr Relat Cancer       Date:  2013-01-07       Impact factor: 5.678

9.  Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases.

Authors:  Karine Lefort; Anna Mandinova; Paola Ostano; Vihren Kolev; Valerie Calpini; Ingrid Kolfschoten; Vikram Devgan; Jocelyn Lieb; Wassim Raffoul; Daniel Hohl; Victor Neel; Jonathan Garlick; Giovanna Chiorino; G Paolo Dotto
Journal:  Genes Dev       Date:  2007-03-01       Impact factor: 11.361

10.  Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.

Authors:  Maria-Giuseppina Procopio; Csaba Laszlo; Dania Al Labban; Dong Eun Kim; Pino Bordignon; Seung-Hee Jo; Sandro Goruppi; Elena Menietti; Paola Ostano; Ugo Ala; Paolo Provero; Wolfram Hoetzenecker; Victor Neel; Witold W Kilarski; Melody A Swartz; Cathrin Brisken; Karine Lefort; G Paolo Dotto
Journal:  Nat Cell Biol       Date:  2015-08-24       Impact factor: 28.824

View more
  10 in total

1.  The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI.

Authors:  Sandro Goruppi; Maria-Giuseppina Procopio; Seunghee Jo; Andrea Clocchiatti; Victor Neel; G Paolo Dotto
Journal:  Cell Rep       Date:  2017-09-05       Impact factor: 9.423

2.  Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B.

Authors:  Dania Al Labban; Seung-Hee Jo; Paola Ostano; Chiara Saglietti; Massimo Bongiovanni; Renato Panizzon; G Paolo Dotto
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

3.  WDR63 inhibits Arp2/3-dependent actin polymerization and mediates the function of p53 in suppressing metastasis.

Authors:  Kailiang Zhao; Decai Wang; Xiaolong Zhao; Chenfeng Wang; Yongxiang Gao; Kaiyue Liu; Fang Wang; Xianning Wu; Xuejuan Wang; Linfeng Sun; Jianye Zang; Yide Mei
Journal:  EMBO Rep       Date:  2020-03-04       Impact factor: 8.807

4.  Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation.

Authors:  Dong Eun Kim; Maria-Giuseppina Procopio; Soumitra Ghosh; Seung-Hee Jo; Sandro Goruppi; Francesco Magliozzi; Pino Bordignon; Victor Neel; Paolo Angelino; G Paolo Dotto
Journal:  J Exp Med       Date:  2017-07-06       Impact factor: 14.307

5.  Notch signaling pathway mediates Doxorubicin-driven apoptosis in cancers.

Authors:  Zixin Huang; Shuibin Lin; Chongde Long; Xin Zhou; Yuting Fan; Xielan Kuang; Jia He; Jie Ning; Han Zhang; Qingjiong Zhang; Huangxuan Shen
Journal:  Cancer Manag Res       Date:  2018-06-08       Impact factor: 3.989

6.  Autophagy Controls CSL/RBPJκ Stability through a p62/SQSTM1-Dependent Mechanism.

Authors:  Sandro Goruppi; Seung-Hee Jo; Csaba Laszlo; Andrea Clocchiatti; Victor Neel; G Paolo Dotto
Journal:  Cell Rep       Date:  2018-09-18       Impact factor: 9.423

7.  CSL controls telomere maintenance and genome stability in human dermal fibroblasts.

Authors:  Giulia Bottoni; Atul Katarkar; Beatrice Tassone; Soumitra Ghosh; Andrea Clocchiatti; Sandro Goruppi; Pino Bordignon; Paris Jafari; Fabio Tordini; Thomas Lunardi; Wolfram Hoetzenecker; Victor Neel; Joachim Lingner; G Paolo Dotto
Journal:  Nat Commun       Date:  2019-08-29       Impact factor: 14.919

8.  Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant.

Authors:  Pino Bordignon; Giulia Bottoni; Xiaoying Xu; Alma S Popescu; Zinnia Truan; Emmanuella Guenova; Lukas Kofler; Paris Jafari; Paola Ostano; Martin Röcken; Victor Neel; G Paolo Dotto
Journal:  Cell Rep       Date:  2019-08-27       Impact factor: 9.423

Review 9.  Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?

Authors:  Venus Sosa Iglesias; Lorena Giuranno; Ludwig J Dubois; Jan Theys; Marc Vooijs
Journal:  Front Oncol       Date:  2018-07-24       Impact factor: 6.244

10.  Tumor suppressor p53: from engaging DNA to target gene regulation.

Authors:  Morgan A Sammons; Thuy-Ai T Nguyen; Simon S McDade; Martin Fischer
Journal:  Nucleic Acids Res       Date:  2020-09-18       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.